Providing a diverse range of perspectives from bullish to bearish, 8 analysts have published ratings on Eastman Chemical EMN in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 0 | 4 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 3 | 0 | 3 | 0 | 0 |
Analysts have set 12-month price targets for Eastman Chemical, revealing an average target of $111.88, a high estimate of $128.00, and a low estimate of $103.00. This upward trend is apparent, with the current average reflecting a 10.23% increase from the previous average price target of $101.50.
Breaking Down Analyst Ratings: A Detailed Examination
A comprehensive examination of how financial experts perceive Eastman Chemical is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| John Roberts | Mizuho | Raises | Neutral | $107.00 | $102.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $111.00 | $114.00 |
| Joshua Spector | UBS | Raises | Buy | $128.00 | $106.00 |
| Michael Leithead | Barclays | Raises | Equal-Weight | $103.00 | $85.00 |
| Arun Viswanathan | RBC Capital | Raises | Sector Perform | $104.00 | $100.00 |
| Charles Neivert | Piper Sandler | Raises | Neutral | $105.00 | $90.00 |
| Laurence Alexander | Jefferies | Raises | Buy | $125.00 | $102.00 |
| Steve Byrne | B of A Securities | Lowers | Buy | $112.00 | $113.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Eastman Chemical. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Eastman Chemical compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Eastman Chemical's stock. This examination reveals shifts in analysts' expectations over time.
To gain a panoramic view of Eastman Chemical's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
Stay up to date on Eastman Chemical analyst ratings.
Unveiling the Story Behind Eastman Chemical
Established in 1920 to produce chemicals for Eastman Kodak, Eastman Chemical has grown into a global specialty chemical company with manufacturing sites around the world. The company generates the majority of its sales outside of the United States, with a strong presence in Asian markets. During the past several years, Eastman has sold noncore businesses, choosing to focus on higher-margin specialty product offerings.
Eastman Chemical: Delving into Financials
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Eastman Chemical's revenue growth over 3 months faced difficulties. As of 31 March, 2024, the company experienced a decline of approximately -4.23%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Net Margin: Eastman Chemical's net margin excels beyond industry benchmarks, reaching 7.14%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Eastman Chemical's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.0% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Eastman Chemical's ROA stands out, surpassing industry averages. With an impressive ROA of 1.12%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Eastman Chemical's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.92.
How Are Analyst Ratings Determined?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
